JCO precision oncology
Journal
Overview
publication venue for
-
Poly (ADP-ribose) Polymerase Inhibitor Resistance Driven by Emergence of Polyclonal Mutations With Convergent Evolution: A Molecular Tumor Board Discussion.
2024
-
Consideration of a Novel Surgical Approach in the Management of Gastric Adenocarcinoma and Proximal Polyposis Syndrome.
2024
-
Germline SMARCA4 Deletion as a Driver of Uterine Cancer: An Atypical Presentation.
2022
-
Genomic Characterization of a RET Inhibitor-Resistant RET Fusion-Positive Lung Cancer by CSF Cell-Free DNA Hybrid Capture-Based Sequencing.
2020
-
Lorlatinib and Bevacizumab Activity in ALK-Rearranged Lung Cancers After Lorlatinib Progression.
2020
-
Acquisition of APOBEC Mutagenesis and Microsatellite Instability Signatures in the Development of Brain Metastases in Low-Grade, Early-Stage Endometrioid Endometrial Carcinoma.
2020
-
FGFR1 Rearrangement Guides Diagnosis and Treatment of a Trilineage B, T, and Myeloid Mixed Phenotype Acute Leukemia.
2020
-
Pathogenic Loss-of-Function Germline TERT Mutations in Patients With Solid Tumors.
2019
-
Prioritization of Therapy Options for a Patient With High Tumor Mutation Burden and Microsatellite Instability but No Clinical Benefit From Immunotherapy.
2019
-
Larotrectinib Demonstrates CNS Efficacy in TRK Fusion-Positive Solid Tumors.
2019
-
Amplification of MYC and Its Enhancer Correlates With Genetic Ancestry in Lung Squamous Cell Carcinoma..
8.
2024
-
Combination of MDM2 and Targeted Kinase Inhibitors Results in Prolonged Tumor Control in Lung Adenocarcinomas With Oncogenic Tyrosine Kinase Drivers and MDM2 Amplification..
8.
2024
-
Early Circulating Tumor DNA Shedding Kinetics for Prediction of Platinum Sensitivity in Patients With Small Cell Lung Cancer..
8.
2024
-
Extrahepatic Cholangiocarcinoma: Genomic Variables Associated With Anatomic Location and Outcome..
8.
2024
-
Transcriptomic Profiling of Primary Prostate Cancers and Nonlocalized Disease on Prostate-Specific Membrane Antigen Positron Emission Tomography/Computed Tomography: A Multicenter Retrospective Study..
8.
2024
-
Inherited Germline Variants in Urinary Tract Cancer: A Multicenter Whole-Exome Sequencing Analysis and Correlation With Clinical Features and Tumor Genomics..
8.
2024
-
Serial Cell-Free DNA Sequencing in ROS1 Fusion-Positive Lung Cancers During Treatment With Entrectinib..
8.
2024
-
Urine Biopsy as Dynamic Biomarker to Enhance Clinical Staging of Bladder Cancer in Radical Cystectomy Candidates..
8.
2024
-
Suggestions on Using Machine Learning Models and Cautions for Analyzing Censored Time-To-Event Outcomes..
8.
2024
-
NF1-Driven Rhabdomyosarcoma Phenotypes: A Comparative Clinical and Molecular Study of NF1-Mutant Rhabdomyosarcoma and NF1-Associated Malignant Triton Tumor..
8.
2024
-
Natural History and Genomic Landscape of Chemotherapy-Resistant Muscle-Invasive Bladder Cancer..
8.
2024
-
Prognostic Implications of Small Cell Lung Cancer Transcriptional Subtyping for CNS Metastases..
8.
2024
-
Concordance in Oncogenic Alterations Between the Primary Tumor and Advanced Disease: Insights Into the Heterogeneity of Intrahepatic Cholangiocarcinoma..
8.
2024
-
Cellular Mass Response to Therapy Correlates With Clinical Response for a Range of Malignancies..
8.
2024
-
Germline Pathogenic Variants and Genetic Counseling by Ancestry in Patients With Epithelial Ovarian Cancer..
7.
2023
-
Targeted Molecular Profiling of Circulating Cell-Free DNA in Patients With Advanced Hepatocellular Carcinoma..
7.
2023
-
Associations Between Cancer Predisposition Mutations and Clonal Hematopoiesis in Patients With Solid Tumors..
7.
2023
-
Clinical and Genomic Features of Response and Toxicity to Sotorasib in a Real-World Cohort of Patients With Advanced KRAS G12C-Mutant Non-Small Cell Lung Cancer..
7.
2023
-
Genomics of ERBB2-Positive Breast Cancer in Young Women Before and After Exposure to Chemotherapy Plus Trastuzumab..
7.
2023
-
Cyclin-Dependent Kinase 4/6 Inhibitors Beyond Progression in Metastatic Breast Cancer: A Retrospective Real-World Biomarker Analysis..
7.
2023
-
Prevalence and Clinical Implications of Mismatch Repair-Proficient Colorectal Cancer in Patients With Lynch Syndrome..
7.
2023
-
Clinical Targeted Next-Generation Panel Sequencing Reveals MYC Amplification Is a Poor Prognostic Factor in Osteosarcoma..
7.
2023
-
Pathway Alterations in Stage II/III Primary Melanoma..
7.
2023
-
Clinicopathologic and Molecular Analysis of Normal Karyotype Therapy-Related and De Novo Acute Myeloid Leukemia: A Multi-Institutional Study by the Bone Marrow Pathology Group..
7.
2023
-
Germline Genetic and Treatment-Related Risk Factors for Diabetes Mellitus in Survivors of Childhood Cancer: A Report From the Childhood Cancer Survivor Study and St Jude Lifetime Cohorts..
6.
2022
-
Rare FGFR Oncogenic Alterations in Sequenced Pediatric Solid and Brain Tumors Suggest FGFR Is a Relevant Molecular Target in Childhood Cancer..
6.
2022
-
Histology-Specific Prognostication for Radiation-Associated Soft Tissue Sarcoma..
6.
2022
-
Predictive Model to Guide Brain Magnetic Resonance Imaging Surveillance in Patients With Metastatic Lung Cancer: Impact on Real-World Outcomes..
6.
2022
-
Addition of Germline Testing to Tumor-Only Sequencing Improves Detection of Pathogenic Germline Variants in Men With Advanced Prostate Cancer..
6.
2022
-
Prospective Clinical Genomic Profiling of Ewing Sarcoma: ERF and FGFR1 Mutations as Recurrent Secondary Alterations of Potential Biologic and Therapeutic Relevance..
6.
2022
-
Matched Molecular Profiling of Cell-Free DNA and Tumor Tissue in Patients With Advanced Clear Cell Renal Cell Carcinoma..
6.
2022
-
Longitudinal Shifts of Solid Tumor and Liquid Biopsy Sequencing Concordance in Metastatic Breast Cancer..
6.
2022
-
Clinical and Genomic Characterization of Bladder Carcinomas With Glandular Phenotype..
6.
2022
-
Genomic Landscape of Advanced Solid Tumors in Circulating Tumor DNA and Correlation With Tissue Sequencing: A Single Institution's Experience..
6.
2022
-
Selpercatinib-Induced Hypothyroidism Through Off-Target Inhibition of Type 2 Iodothyronine Deiodinase..
6.
2022
-
Mutant PPM1D- and TP53-Driven Hematopoiesis Populates the Hematopoietic Compartment in Response to Peptide Receptor Radionuclide Therapy..
6.
2022
-
Germline Sequencing Improves Tumor-Only Sequencing Interpretation in a Precision Genomic Study of Patients With Pediatric Solid Tumor..
5.
2021
-
Germline Testing Data Validate Inferences of Mutational Status for Variants Detected From Tumor-Only Sequencing..
5.
2021
-
TERT Promoter Mutations Are Enriched in Oral Cavity Cancers and Associated With Locoregional Recurrence..
5.
2021
-
Differential Activity of PARP Inhibitors in BRCA1- Versus BRCA2-Altered Metastatic Castration-Resistant Prostate Cancer..
5.
2021
-
Longitudinal Dynamics of Circulating Tumor Cells and Circulating Tumor DNA for Treatment Monitoring in Metastatic Breast Cancer..
5.
2021
-
Tumor-Infiltrating Lymphocytes, Tumor Mutational Burden, and Genetic Alterations in Microsatellite Unstable, Microsatellite Stable, or Mutant POLE/POLD1 Colon Cancer..
5.
2021
-
Differential Impact of ALK Mutations in Neuroblastoma..
5.
2021
-
Prevalence and Characterization of Biallelic and Monoallelic NTHL1 and MSH3 Variant Carriers From a Pan-Cancer Patient Population..
5.
2021
-
Utility of Serial cfDNA NGS for Prospective Genomic Analysis of Patients on a Phase I Basket Study..
5.
2021
-
Identification of a Microsatellite Stable, EGFR-Mutant Lung Adenocarcinoma Developing in a Patient With Lynch Syndrome..
4.
2020
-
Germ Cell Tumor Molecular Heterogeneity Revealed Through Analysis of Primary and Metastasis Pairs..
4.
2020
-
Prospective Multicenter Study of Circulating Tumor Cell AR-V7 and Taxane Versus Hormonal Treatment Outcomes in Metastatic Castration-Resistant Prostate Cancer..
4.
2020
-
Dickkopf-1 Can Lead to Immune Evasion in Metastatic Castration-Resistant Prostate Cancer..
4.
2020
-
Genomic Alterations as Potential Therapeutic Targets in Extramammary Paget's Disease of the Vulva..
4.
2020
-
Systematic Assessment of Tumor Purity and Its Clinical Implications..
4.
2020
-
CNS Metastases in Patients With MET Exon 14-Altered Lung Cancers and Outcomes With Crizotinib..
4.
2020
-
BRCA Mutations, Homologous DNA Repair Deficiency, Tumor Mutational Burden, and Response to Immune Checkpoint Inhibition in Recurrent Ovarian Cancer..
4.
2020
-
P2RY8-CRLF2Fusion-Positive Acute Myeloid Leukemia With Myelodysplasia-Related Changes: Response to Novel Therapy..
4.
2020
-
Identifying ERBB2 Activating Mutations in HER2-Negative Breast Cancer: Clinical Impact of Institute-Wide Genomic Testing and Enrollment in Matched Therapy Trials..
3.
2019
-
Harmonization of Tumor Mutational Burden Quantification and Association With Response to Immune Checkpoint Blockade in Non-Small-Cell Lung Cancer..
3.
2019
-
Genomic Characterization of ERBB2-Driven Biliary Cancer and a Case of Response to Ado-Trastuzumab Emtansine..
3.
2019
-
Integrative Molecular Analysis of Patients With Advanced and Metastatic Cancer..
3.
2019
-
Cancer-Specific Thresholds Adjust for Whole Exome Sequencing-based Tumor Mutational Burden Distribution..
3.
2019
-
Real-World Outcomes of an Automated Physician Support System for Genome-Driven Oncology..
3.
2019
-
Response to Selective RET Inhibition With LOXO-292 in a Patient With RET Fusion-Positive Lung Cancer With Leptomeningeal Metastases..
3.
2019
-
Immunophenotype and Response to Immunotherapy of RET-Rearranged Lung Cancers..
3.
2019
-
Acquired MET Exon 14 Alteration Drives Secondary Resistance to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor in EGFR-Mutated Lung Cancer..
3.
2019
-
Understanding inherited risk in unselected newly diagnosed patients with endometrial cancer..
3.
2019
-
Harnessing Clinical Sequencing Data for Survival Stratification of Patients with Metastatic Lung Adenocarcinomas..
3.
2019
-
Majority of B2M-Mutant and -Deficient Colorectal Carcinomas Achieve Clinical Benefit From Immune Checkpoint Inhibitor Therapy and Are Microsatellite Instability-High..
3.
2019
-
Targeting HER2/neu Oncogene Overexpression With Ado-Trastuzumab Emtansine in the Treatment of Metastatic Salivary Gland Neoplasms: A Single-Institution Experience..
3.
2019
-
Targeted Next-Generation Sequencing Reveals Clinically Actionable BRAF and ESR1 Mutations in Low-Grade Serous Ovarian Carcinoma..
2018.
2018
-
Dramatic Response to Sequential BRAF Inhibition in BRAF V600E-Mutant Metastatic Lung Adenocarcinoma..
2.
2018
-
Elevated Levels of BRAFV600 Mutant Circulating Tumor DNA and Circulating Hepatocyte Growth Factor Are Associated With Poor Prognosis in Patients With Metastatic Melanoma..
2.
2018
-
Entrectinib in Two Pediatric Patients With Inflammatory Myofibroblastic Tumors Harboring ROS1 or ALK Gene Fusions..
2.
2018
-
Acquired ALK and RET Gene Fusions as Mechanisms of Resistance to Osimertinib in EGFR-Mutant Lung Cancers..
2.
2018
-
Evolving Intersection Between Inherited Cancer Genetics and Therapeutic Clinical Trials in Prostate Cancer: A White Paper From the Germline Genetics Working Group of the Prostate Cancer Clinical Trials Consortium..
2018.
2018
-
Genomic Heterogeneity Underlies Mixed Response to Tropomyosin Receptor Kinase Inhibition in Recurrent Glioma..
2.
2018
-
Impact of the SPOP Mutant Subtype on the Interpretation of Clinical Parameters in Prostate Cancer..
2018.
2018
-
Clinicopathologic Features of Non-Small-Cell Lung Cancer Harboring an NTRK Gene Fusion..
2018.
2018
-
BRCA2-Associated Prostate Cancer in a Patient With Spinal and Bulbar Muscular Atrophy..
2.
2018
-
Real-Time Genomic Characterization of Metastatic Pancreatic Neuroendocrine Tumors Has Prognostic Implications and Identifies Potential Germline Actionability..
2018.
2018
-
Acquired Resistance to Poly (ADP-ribose) Polymerase Inhibitor Olaparib in BRCA2-Associated Prostate Cancer Resulting From Biallelic BRCA2 Reversion Mutations Restores Both Germline and Somatic Loss-of-Function Mutations..
2.
2018
-
Genomic Characterization of Upper-Tract Urothelial Carcinoma in Patients With Lynch Syndrome..
2018.
2018
-
Specifying the True- and False-Positive Rates in Basket Trials..
1.
2017
-
DNA Methylation-Based Classifier for Accurate Molecular Diagnosis of Bone Sarcomas..
2017.
2017
-
Reliable Pan-Cancer Microsatellite Instability Assessment by Using Targeted Next-Generation Sequencing Data..
2017.
2017
-
Successful Targeted Therapy of Refractory Pediatric ETV6-NTRK3 Fusion-Positive Secretory Breast Carcinoma..
2017.
2017
-
PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma..
1.
2017
-
Next-Generation Rapid Autopsies Enable Tumor Evolution Tracking and Generation of Preclinical Models..
2017.
2017
-
Personalized Medicine in the Oncology Clinic: Implementation and Outcomes of the Johns Hopkins Molecular Tumor Board..
2017.
2017
-
Prospective Genomic Profiling of Prostate Cancer Across Disease States Reveals Germline and Somatic Alterations That May Affect Clinical Decision Making..
2017.
2017
-
Plasma DNA-based molecular diagnosis, prognostication, and monitoring of patients with EWSR1 fusion-positive sarcomas..
2017.
2017
-
OncoKB: A Precision Oncology Knowledge Base..
2017.
2017
-
Persistent Severe Hyperlactatemia and Metabolic Derangement in Lethal SDHB-Mutated Metastatic Kidney Cancer: Clinical Challenges and Examples of Extreme Warburg Effect.
2017
-
Intermittent Treatment With MEK Inhibitors in Patients With Oncogenic RAF-Driven Tumors: A Potential Strategy to Manage Toxicity and Maintain Efficacy.
2018
-
Expanding the Reach of Personalized Medicine in Cancer Care: Current Progress and Future Directions of JCO Precision Oncology..
8.
2024
-
Implementation of Whole-Genome and Transcriptome Sequencing Into Clinical Cancer Care.
2022
Identity
ISO Abbreviation
Linking ISSN
International Standard Serial Number (ISSN)
Electronic International Standard Serial Number (EISSN)